Shanghai Yizhong Pharmaceutical Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shanghai Yizhong Pharmaceutical Co., Ltd. - overview
Established
2009
Location
Shanghai, Shanghai, China
Primary Industry
Pharmaceuticals
About
Based in Shanghai, China and established in 2009, Shanghai Yizhong Pharmaceutical Co. , Ltd. is a pharmaceutical company that focuses on the development of new dosage forms of anti-tumor drugs and related products. In 2021, the company was listed on the Shanghai Stock Exchange.
The company engages in the development of new dosage forms of anti-tumor drugs and related products. Its main product is paclitaxel polymer micelles for injection. Paclitaxel polymer micelles for injection is a lyophilized preparation of paclitaxel nano-micelle particles with 1. 1 types of pharmaceutical excipients as a carrier, which is used in the treatment of malignant tumors.
Current Investors
Hankang Capital, Addor Capital, Shengduo Jinji
Primary Industry
Pharmaceuticals
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.yizhongpharma.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.